Share
Risk-Benefit Analysis in Drug Research: Proceedings of an International Symposium Held at the University of Kent at Canterbury, England, 27 March 1980
Cavalla, J. F. (Author)
·
Springer
· Paperback
Risk-Benefit Analysis in Drug Research: Proceedings of an International Symposium Held at the University of Kent at Canterbury, England, 27 March 1980 - Cavalla, J. F.
Choose the list to add your product or create one New List
✓ Product added successfully to the Wishlist.
Go to My Wishlists
Origin: U.S.A.
(Import costs included in the price)
It will be shipped from our warehouse between
Monday, July 22 and
Monday, July 29.
You will receive it anywhere in United Kingdom between 1 and 3 business days after shipment.
Synopsis "Risk-Benefit Analysis in Drug Research: Proceedings of an International Symposium Held at the University of Kent at Canterbury, England, 27 March 1980"
The appreciation of risk like the awareness of beauty lies very much in the eyes of the beholder. It involves a value judgement and can never be absolute. Yet paradoxically, modern society is demanding ever greater degrees of safety in the medicines it takes, to the extent that nothing short of the total absence of risk will be tolerated. Since 1960, and mainly as a result of the thalidomide tragedy, governmental regulation of testing and use of new medicines has grown apace throughout the world. It has derived impetus not only from the understandable wish of the public to seek protection, but also from the anxiety of bureaucrats and politicians not to be seen to have made mistakes. Both these concerns have been inflamed by the recognition of the media that all drugs make news and horror drugs make the best news of all. Prior to this time the physician and his cures enjoyed a relatively supportive public. It was true that quacks existed and were recognized as such but, in the main, people wanted to take medicines and expected them to do them good.
